prod:prod_dcx-login
Faster Access To Better Quality Results
Making Molecular Testing Fast, Easy & Flexible
We’re striving to help you deliver better care in less time. Only Cepheid’s GeneXpert® System is equipped to provide fast, high-quality results wherever and whenever you need them.
As simple as 1, 2, 3
Video
Meet our Game-Changing Platform
With over 36,000 installed systems worldwide, the GeneXpert System is the most popular sample-to-answer PCR testing system. See how it’s helping clinicians everywhere make a more positive impact.
Video
Journey Inside the Cepheid GeneXpert® Cartridge
Delivering better care begins with using the best technology. See how Cepheid’s GeneXpert cartridge technology is paving the way for more innovative medicine.
Video
Laboratory Alliance – Decision and Impact
Dr. Paul A. Granato, Director of Microbiology at Laboratory Alliance of Central New York, leverages the GeneXpert® System to improve patient care, elevate his institution’s ability to control infection, and help create better ways for his physicians.
Video
Meet our Game-Changing Platform
With over 36,000 installed systems worldwide, the GeneXpert System is the most popular sample-to-answer PCR testing system. See how it’s helping clinicians everywhere make a more positive impact.
Video
Journey Inside the Cepheid GeneXpert® Cartridge
Delivering better care begins with using the best technology. See how Cepheid’s GeneXpert cartridge technology is paving the way for more innovative medicine.
Video
Laboratory Alliance – Decision and Impact
Dr. Paul A. Granato, Director of Microbiology at Laboratory Alliance of Central New York, leverages the GeneXpert® System to improve patient care, elevate his institution’s ability to control infection, and help create better ways for his physicians.
Webinars
Bringing Molecular Testing Closer to the Patient
Over the past 20 years, there has been a continuous shift toward the decentralization of clinical laboratory testing. With recent advances in the speed and accuracy of point-of-care tests, it is now possible to bring molecular infectious disease testing closer to the patient. This webinar explores the benefits of molecular point-of-care testing as a means of improving patient outcomes and quality of care. Currently available testing methods are reviewed, with an emphasis on the importance of lab testing in the era of performance-driven healthcare.
More...
PCR is Better than RIDT: IDSA Says So- Laboratory Perspective (Part 1 of a 2-part series)
Ten years after the 2009 H1N1 outbreak occurred, the IDSA updated the guidelines for the management of influenza. Learn about the new recommendations for diagnostic and treatment protocols. Hear firsthand examples from the laboratory perspective. Learn how this updated approach can streamline laboratory workflows and improve patient care.
This is the first segment of a two-part series. The second webinar explores the IDSA guidelines from a clinician's perspective.
More...
Getting It Fast vs. Getting It Right- Clinician Perspective (Part 2 of a 2-part series)
Ten years after the 2009 H1N1 outbreak occurred, the IDSA updated the guidelines for the management of influenza. Learn about the new recommendations for diagnostic and treatment protocols. Hear firsthand examples from the laboratory perspective. Learn how this updated approach can streamline laboratory workflows and improve patient care.
More...
Simplification of testing and treatment in the quest to eliminate hepatitis C infection
Globally, 71 million people are living with hepatitis C virus (HCV) infection, but the burden of HCV continues to increase. Between 2015 and 2030, WHO targets include reducing new HCV infections by 80% and HCV deaths by 65%, and increasing HCV diagnoses from <20% to 90% and the number of eligible persons receiving HCV treatment from <10% to 80%. To achieve these targets, targeted interventions are needed to enhance HCV testing, linkage to care, and treatment (“the HCV care cascade”). This presentation reviews available evidence on strategies that have been successfully used to enhance HCV testing, linkage to care.
More...
Chlamydia and Gonorrhea testing in the ED and the Need for Evidence Based Medicine
In this webinar, Dr. Larissa May discusses the diagnosis of sexually transmitted infections in the Emergency Department, the need for evidence-based medicine, and how same-visit treatment and management can be facilitated with on-demand testing for CT/NG.
More...
Acute Pharyngitis Visits in the ED: What’s the Big Deal?
Acute pharyngitis is a frequent complaint seen in the Emergency Department, and group A Streptococcus is the most common bacterial etiology of pediatric pharyngitis. Globally, 616 million people are diagnosed annually with group A Streptococcus (GAS) pharyngitis. Of these, 18.1 million cases develop severe GAS disease, and 517,000 people die every year due to GAS disease.
Understand why the status quo of testing has led to missing GAS cases and overuse of antibiotics for treatment. Learn how new advances in rapid molecular testing can improve your test results and aid in effective management of your patients.
More...
Key Links
Cepheid GeneXpert Systems
Tests
